After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Standard BioTools Inc is listed on the NASDAQ in the Healthcare sector while operating in the Medical Devices industry. The current market capitalization of Standard BioTools Inc is $398.81M. A total of 1.57 million shares were traded on the day, compared to an average of 1.46M shares.
In the most recent transaction, Kim Hanjoon Alex sold 1,428 shares of LAB for 0.94 per share on May 23 ’25. After the transaction, the Chief Financial Officer now owns 930,286 company shares. In a previous transaction on May 23 ’25, Mackay Sean sold 13,217 shares at 0.94 per share. LAB shares that SVP & Chief Business Officer owns now total 843,076.
Among the insiders who sold shares, Egholm Michael disposed of 5,473 shares on May 23 ’25 at a per-share price of $0.94. This resulted in the President & CEO holding 2,741,191 shares of LAB after the transaction. In another insider transaction, Kim Hanjoon Alex sold 1,355 shares at $1.00 per share on May 22 ’25. Company shares held by the Chief Financial Officer now total 931,714.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, LAB has a high of $2.60 and a low of $0.92.
As of this writing, LAB has an earnings estimate of -$0.04 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.04 per share and a lower estimate of -$0.04.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. LAB’s latest balance sheet shows that the firm has $28.45M in Cash & Short Term Investments as of fiscal 2021. There were $111.65M in debt and $49.57M in liabilities at the time. Its Book Value Per Share was $1.20, while its Total Shareholder’s Equity was $94.60M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LAB is Buy with a score of 4.33.
